{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T15:25:29Z","timestamp":1760369129692},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2013,5,30]],"date-time":"2013-05-30T00:00:00Z","timestamp":1369872000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s00702-013-1037-6","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T13:31:58Z","timestamp":1369834318000},"page":"49-53","source":"Crossref","is-referenced-by-count":6,"title":["Advancing therapeutic options in multiple sclerosis with neuroprotective properties"],"prefix":"10.1007","volume":"120","author":[{"given":"Anke","family":"Stroet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf A.","family":"Linker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,30]]},"reference":[{"issue":"24","key":"1037_CR1","doi-asserted-by":"crossref","first-page":"14157","DOI":"10.1073\/pnas.2336171100","volume":"100","author":"R Aharoni","year":"2003","unstructured":"Aharoni R, Kayhan B, Eilam R, Sela M, Arnon R (2003) Glatiramer acetate-specific T cells in the brain express T helper 2\/3 cytokines and brain-derived neurotrophic factor in situ. Proc Natl Acad Sci USA 100(24):14157\u201314162. doi: 10.1073\/pnas.2336171100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"1037_CR2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jneuroim.2012.06.005","volume":"251","author":"R Aharoni","year":"2012","unstructured":"Aharoni R, Saada R, Eilam R, Hayardeny L, Sela M, Arnon R (2012) Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 251(1\u20132):14\u201324. doi: 10.1016\/j.jneuroim.2012.06.005","journal-title":"J Neuroimmunol"},{"issue":"10","key":"1037_CR3","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1177\/1352458512439237","volume":"18","author":"P Albrecht","year":"2012","unstructured":"Albrecht P, Ringelstein M, Muller AK, Keser N, Dietlein T, Lappas A, Foerster A, Hartung HP, Aktas O, Methner A (2012) Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography. Mult Scler 18(10):1422\u20131429. doi: 10.1177\/1352458512439237","journal-title":"Mult Scler"},{"issue":"6","key":"1037_CR4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0190-9622(94)70121-0","volume":"30","author":"PJ Altmeyer","year":"1994","unstructured":"Altmeyer PJ, Matthes U, Pawlak F, Hoffmann K, Frosch PJ, Ruppert P, Wassilew SW, Horn T, Kreysel HW, Lutz G et al (1994) Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 30(6):977\u2013981","journal-title":"J Am Acad Dermatol"},{"key":"1037_CR5","author":"MP Amato","year":"2012","unstructured":"Amato MP, Langdon D, Montalban X, Benedict RH, Deluca J, Krupp LB, Thompson AJ, Comi G (2012) Treatment of cognitive impairment in multiple sclerosis: position paper. J Neurol. doi: 10.1007\/s00415-012-6678-0","journal-title":"J Neurol"},{"issue":"8","key":"1037_CR6","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1073\/pnas.0530191100","volume":"100","author":"DN Angelov","year":"2003","unstructured":"Angelov DN, Waibel S, Guntinas-Lichius O, Lenzen M, Neiss WF, Tomov TL, Yoles E, Kipnis J, Schori H, Reuter A, Ludolph A, Schwartz M (2003) Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 100(8):4790\u20134795. doi: 10.1073\/pnas.0530191100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"1037_CR7","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1002\/eji.200424883","volume":"34","author":"H Avidan","year":"2004","unstructured":"Avidan H, Kipnis J, Butovsky O, Caspi RR, Schwartz M (2004) Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+\u00a0CD25+\u00a0T cells. Eur J Immunol 34(12):3434\u20133445. doi: 10.1002\/eji.200424883","journal-title":"Eur J Immunol"},{"key":"1037_CR8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/mcne.1996.0053","volume":"8","author":"BA Barres","year":"1996","unstructured":"Barres BA (1996) Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation. Mol Cell Neurosci 8:146\u2013156","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"1037_CR9","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1352458512454346","volume":"19","author":"L Bosma","year":"2013","unstructured":"Bosma L, Kragt J, Polman C, Uitdehaag B (2013) Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS. Mult Scler 19(3):326\u2013333. doi: 10.1177\/1352458512454346","journal-title":"Mult Scler"},{"issue":"3","key":"1037_CR10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00401-012-1009-1","volume":"124","author":"W Bruck","year":"2012","unstructured":"Bruck W, Pfortner R, Pham T, Zhang J, Hayardeny L, Piryatinsky V, Hanisch UK, Regen T, van Rossum D, Brakelmann L, Hagemeier K, Kuhlmann T, Stadelmann C, John GR, Kramann N, Wegner C (2012) Reduced astrocytic NF-kappaB activation by laquinimod protects from cuprizone-induced demyelination. Acta Neuropathol 124(3):411\u2013424. doi: 10.1007\/s00401-012-1009-1","journal-title":"Acta Neuropathol"},{"issue":"11","key":"1037_CR11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1056\/NEJMoa1104318","volume":"366","author":"G Comi","year":"2012","unstructured":"Comi G, Jeffery D, Kappos L, Montalban X, Boyko A, Rocca MA, Filippi M (2012) Placebo-controlled trial of oral laquinimod for multiple sclerosis. N Engl J Med 366(11):1000\u20131009. doi: 10.1056\/NEJMoa1104318","journal-title":"N Engl J Med"},{"issue":"Pt 6","key":"1037_CR12","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/brain\/118.6.1583","volume":"118","author":"CA Davie","year":"1995","unstructured":"Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE, McDonald WI, Miller DH (1995) Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 118(Pt 6):1583\u20131592","journal-title":"Brain"},{"issue":"Pt 8","key":"1037_CR13","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/brain\/121.8.1469","volume":"121","author":"N Stefano De","year":"1998","unstructured":"De Stefano N, Matthews PM, Fu L, Narayanan S, Stanley J, Francis GS, Antel JP, Arnold DL (1998) Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 121(Pt 8):1469\u20131477","journal-title":"Brain"},{"issue":"12","key":"1037_CR14","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","volume":"367","author":"RJ Fox","year":"2012","unstructured":"Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT (2012) Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med 367(12):1087\u20131097. doi: 10.1056\/NEJMoa1206328","journal-title":"N Engl J Med"},{"issue":"12","key":"1037_CR15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ncpneuro0950","volume":"4","author":"EM Frohman","year":"2008","unstructured":"Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ (2008) Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 4(12):664\u2013675. doi: 10.1038\/ncpneuro0950","journal-title":"Nat Clin Pract Neurol"},{"issue":"1","key":"1037_CR16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13311-010-0005-1","volume":"8","author":"KM Galetta","year":"2011","unstructured":"Galetta KM, Calabresi PA, Frohman EM, Balcer LJ (2011) Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics 8(1):117\u2013132. doi: 10.1007\/s13311-010-0005-1","journal-title":"Neurotherapeutics"},{"issue":"Pt 8","key":"1037_CR17","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","volume":"129","author":"R Gold","year":"2006","unstructured":"Gold R, Linington C, Lassmann H (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70\u00a0years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129(Pt 8):1953\u20131971. doi: 10.1093\/brain\/awl075","journal-title":"Brain"},{"issue":"12","key":"1037_CR18","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","volume":"367","author":"R Gold","year":"2012","unstructured":"Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT (2012) Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 367(12):1098\u20131107. doi: 10.1056\/NEJMoa1114287","journal-title":"N Engl J Med"},{"key":"1037_CR19","doi-asserted-by":"crossref","unstructured":"Goodin DS, Ebers GC, Cutter G, Cook SD, O\u2019Donnell T, Reder AT, Kremenchutzky M, Oger J, Rametta M, Beckmann K, Knappertz V (2012) Cause of death in MS: long-term follow-up of a randomised cohort, 21\u00a0years after the start of the pivotal IFNbeta-1b study. BMJ Open 2(6). doi: 10.1136\/bmjopen-2012-001972","DOI":"10.1136\/bmjopen-2012-001972"},{"issue":"7","key":"1037_CR20","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.4049\/jimmunol.179.7.4345","volume":"179","author":"S Gorantla","year":"2007","unstructured":"Gorantla S, Liu J, Sneller H, Dou H, Holguin A, Smith L, Ikezu T, Volsky DJ, Poluektova L, Gendelman HE (2007) Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis. J Immunol 179(7):4345\u20134356","journal-title":"J Immunol"},{"issue":"3","key":"1037_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1756285610368890","volume":"3","author":"BM Greenberg","year":"2010","unstructured":"Greenberg BM, Frohman E (2010) Optical coherence tomography as a potential readout in clinical trials. Ther Adv Neurol Disord 3(3):153\u2013160. doi: 10.1177\/1756285610368890","journal-title":"Ther Adv Neurol Disord"},{"key":"1037_CR22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.0105-2896.2005.00240.x","volume":"204","author":"DA Hafler","year":"2005","unstructured":"Hafler DA, Slavik JM, Anderson DE, O\u2019Connor KC, De Jager P, Baecher-Allan C (2005) Multiple sclerosis. Immunol Rev 204:208\u2013231. doi: 10.1111\/j.0105-2896.2005.00240.x","journal-title":"Immunol Rev"},{"issue":"8","key":"1037_CR23","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/j.1460-2075.1990.tb07423.x","volume":"9","author":"M Hofer","year":"1990","unstructured":"Hofer M, Pagliusi SR, Hohn A, Leibrock J, Barde YA (1990) Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 9(8):2459\u20132464","journal-title":"EMBO J"},{"issue":"Suppl 2","key":"1037_CR24","doi-asserted-by":"crossref","first-page":"14599","DOI":"10.1073\/pnas.0404874101","volume":"101","author":"R Hohlfeld","year":"2004","unstructured":"Hohlfeld R, Wekerle H (2004) Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. Proc Natl Acad Sci USA 101(Suppl 2):14599\u201314606. doi: 10.1073\/pnas.0404874101","journal-title":"Proc Natl Acad Sci USA"},{"key":"1037_CR25","author":"HE Hulst","year":"2013","unstructured":"Hulst HE, Steenwijk MD, Versteeg A, Pouwels PJ, Vrenken H, Uitdehaag BM, Polman CH, Geurts JJ, Barkhof F (2013) Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions. Neurology. doi: 10.1212\/WNL.0b013e31828726cc","journal-title":"Neurology"},{"issue":"9648","key":"1037_CR26","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(08)61619-0","volume":"372","author":"L Kappos","year":"2008","unstructured":"Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Yang M, Eraksoy M, Meluzinova E, Rektor I, Dawson KT, Sandrock AW, O\u2019Neill GN (2008) Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet 372(9648):1463\u20131472. doi: 10.1016\/S0140-6736(08)61619-0","journal-title":"Lancet"},{"issue":"5","key":"1037_CR27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1084\/jem.189.5.865","volume":"189","author":"M Kerschensteiner","year":"1999","unstructured":"Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R (1999) Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189(5):865\u2013870","journal-title":"J Exp Med"},{"issue":"7","key":"1037_CR28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1471-4914(02)02373-0","volume":"8","author":"J Kipnis","year":"2002","unstructured":"Kipnis J, Schwartz M (2002) Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders. Trends Mol Med 8(7):319\u2013323","journal-title":"Trends Mol Med"},{"key":"1037_CR29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.ne.19.030196.001445","volume":"19","author":"GR Lewin","year":"1996","unstructured":"Lewin GR, Barde YA (1996) Physiology of the neurotrophins. Annu Rev Neurosci 19:289\u2013317. doi: 10.1146\/annurev.ne.19.030196.001445","journal-title":"Annu Rev Neurosci"},{"issue":"6","key":"1037_CR30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nm0602-620","volume":"8","author":"RA Linker","year":"2002","unstructured":"Linker RA, Maurer M, Gaupp S, Martini R, Holtmann B, Giess R, Rieckmann P, Lassmann H, Toyka KV, Sendtner M, Gold R (2002) CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat Med 8(6):620\u2013624. doi: 10.1038\/nm0602-620","journal-title":"Nat Med"},{"issue":"Pt 8","key":"1037_CR31","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1093\/brain\/awq179","volume":"133","author":"RA Linker","year":"2010","unstructured":"Linker RA, Lee DH, Demir S, Wiese S, Kruse N, Siglienti I, Gerhardt E, Neumann H, Sendtner M, Luhder F, Gold R (2010) Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain 133(Pt 8):2248\u20132263. doi: 10.1093\/brain\/awq179","journal-title":"Brain"},{"issue":"Pt 3","key":"1037_CR32","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","volume":"134","author":"RA Linker","year":"2011","unstructured":"Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, Zeng W, Hronowsky X, Buko A, Chollate S, Ellrichmann G, Bruck W, Dawson K, Goelz S, Wiese S, Scannevin RH, Lukashev M, Gold R (2011) Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 134(Pt 3):678\u2013692. doi: 10.1093\/brain\/awq386","journal-title":"Brain"},{"key":"1037_CR33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.8430320","volume":"259","author":"JC Louis","year":"1993","unstructured":"Louis JC, Magal E, Takayama S, Varon S (1993) CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259:689\u2013692","journal-title":"Science"},{"issue":"4","key":"1037_CR34","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","volume":"46","author":"FD Lublin","year":"1996","unstructured":"Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46(4):907\u2013911","journal-title":"Neurology"},{"issue":"12","key":"1037_CR35","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/jnnp.2009.199968","volume":"81","author":"C Lukas","year":"2010","unstructured":"Lukas C, Minneboo A, de Groot V, Moraal B, Knol DL, Polman CH, Barkhof F, Vrenken H (2010) Early central atrophy rate predicts 5\u00a0year clinical outcome in multiple sclerosis. J Neurol Neurosurg Psychiatry 81(12):1351\u20131356. doi: 10.1136\/jnnp.2009.199968","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"1037_CR36","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/01.wnl.0000345042.53843.d5","volume":"72","author":"RT Naismith","year":"2009","unstructured":"Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, Song SK, Cross AH (2009) Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 72(12):1077\u20131082. doi: 10.1212\/01.wnl.0000345042.53843.d5","journal-title":"Neurology"},{"issue":"1","key":"1037_CR37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000247856","volume":"181","author":"C Nieboer","year":"1990","unstructured":"Nieboer C, de Hoop D, Langendijk PN, van Loenen AC, Gubbels J (1990) Fumaric acid therapy in psoriasis: a double-blind comparison between fumaric acid compound therapy and monotherapy with dimethylfumaric acid ester. Dermatologica 181(1):33\u201337","journal-title":"Dermatologica"},{"issue":"12","key":"1037_CR38","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1517\/13543784.2010.534778","volume":"19","author":"A Papadopoulou","year":"2010","unstructured":"Papadopoulou A, D\u2019Souza M, Kappos L, Yaldizli O (2010) Dimethyl fumarate for multiple sclerosis. Expert Opin Investig Drugs 19(12):1603\u20131612. doi: 10.1517\/13543784.2010.534778","journal-title":"Expert Opin Investig Drugs"},{"key":"1037_CR39","author":"A Papadopoulou","year":"2013","unstructured":"Papadopoulou A, Muller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Wilhelm Radue E, Kappos L, Penner IK (2013) Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis. Mult Scler. doi: 10.1177\/1352458513475490","journal-title":"Mult Scler"},{"issue":"10","key":"1037_CR40","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1177\/1352458512442438","volume":"18","author":"IK Penner","year":"2012","unstructured":"Penner IK, Stemper B, Calabrese P, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalban X, Barkhof F, Pleimes D, Lanius V, Pohl C, Kappos L, Sandbrink R (2012) Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis. Mult Scler 18(10):1466\u20131471. doi: 10.1177\/1352458512442438","journal-title":"Mult Scler"},{"issue":"9","key":"1037_CR41","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","volume":"9","author":"A Petzold","year":"2010","unstructured":"Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, Calabresi PA, Polman C (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9(9):921\u2013932. doi: 10.1016\/S1474-4422(10)70168-X","journal-title":"Lancet Neurol"},{"issue":"4","key":"1037_CR42","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1212\/WNL.0b013e3181af78b8","volume":"73","author":"JN Ratchford","year":"2009","unstructured":"Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, Calabresi PA, Kerr DA (2009) Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 73(4):302\u2013308. doi: 10.1212\/WNL.0b013e3181af78b8","journal-title":"Neurology"},{"issue":"2","key":"1037_CR43","first-page":"402","volume":"21","author":"M Rovaris","year":"2000","unstructured":"Rovaris M, Filippi M, Minicucci L, Iannucci G, Santuccio G, Possa F, Comi G (2000) Cortical\/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR 21(2):402\u2013408","journal-title":"AJNR"},{"issue":"6","key":"1037_CR44","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1468-1331.2006.01292.x","volume":"13","author":"S Schimrigk","year":"2006","unstructured":"Schimrigk S, Brune N, Hellwig K, Lukas C, Bellenberg B, Rieks M, Hoffmann V, Pohlau D, Przuntek H (2006) Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study. Eur J Neurology 13(6):604\u2013610. doi: 10.1111\/j.1468-1331.2006.01292.x","journal-title":"Eur J Neurology"},{"issue":"2","key":"1037_CR45","first-page":"103","volume":"13","author":"W Schweckendiek","year":"1959","unstructured":"Schweckendiek W (1959) Treatment of psoriasis vulgaris. Medizinische Monatsschrift 13(2):103\u2013104","journal-title":"Medizinische Monatsschrift"},{"issue":"Pt 1","key":"1037_CR46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/brain\/awf015","volume":"125","author":"C Stadelmann","year":"2002","unstructured":"Stadelmann C, Kerschensteiner M, Misgeld T, Bruck W, Hohlfeld R, Lassmann H (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 125(Pt 1):75\u201385","journal-title":"Brain"},{"issue":"1","key":"1037_CR47","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajpath.2011.09.037","volume":"180","author":"J Thone","year":"2012","unstructured":"Thone J, Ellrichmann G, Seubert S, Peruga I, Lee DH, Conrad R, Hayardeny L, Comi G, Wiese S, Linker RA, Gold R (2012) Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor. Am J Pathol 180(1):267\u2013274. doi: 10.1016\/j.ajpath.2011.09.037","journal-title":"Am J Pathol"},{"issue":"5","key":"1037_CR48","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","volume":"338","author":"BD Trapp","year":"1998","unstructured":"Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338(5):278\u2013285. doi: 10.1056\/NEJM199801293380502","journal-title":"N Engl J Med"},{"issue":"Pt 11","key":"1037_CR49","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/brain\/awf252","volume":"125","author":"T Ziemssen","year":"2002","unstructured":"Ziemssen T, Kumpfel T, Klinkert WE, Neuhaus O, Hohlfeld R (2002) Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor. Brain 125(Pt 11):2381\u20132391","journal-title":"Brain"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-1037-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-013-1037-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-013-1037-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,14]],"date-time":"2019-07-14T06:51:52Z","timestamp":1563087112000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-013-1037-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,30]]},"references-count":49,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["1037"],"URL":"https:\/\/doi.org\/10.1007\/s00702-013-1037-6","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,30]]}}}